🎗️Oncology for The Non-Oncologist🎗️
(A practical educational series for internal medicine trainees and physicians)
Episode 11: When you hear “small cell carcinoma”, think urgency 🚨. Here’s what you need to do…
Listen up - 🧵
(A practical educational series for internal medicine trainees and physicians)
Episode 11: When you hear “small cell carcinoma”, think urgency 🚨. Here’s what you need to do…
Listen up - 🧵
Disclaimer: This thread is for educational purposes only and is not medical advice. Always consult hematology and medical oncology or appropriate specialists for patient-specific decisions.
Let’s start with a case
62 yo male, heavy smoker, comes in with cough, wt loss, new confusion. In the ED CT brain normal but CT chest shows: bulky central mass + liver lesions. Biopsy by IR of a liver lesions showed: small cell carcinoma.
What’s your next move?
62 yo male, heavy smoker, comes in with cough, wt loss, new confusion. In the ED CT brain normal but CT chest shows: bulky central mass + liver lesions. Biopsy by IR of a liver lesions showed: small cell carcinoma.
What’s your next move?
1/ Everyone thinks small cell = lung. Wrong. It can hit prostate, bladder, GI… you name it. It’s rare, but when it shows up, it’s fast and ugly. The kind of cancer you never want to miss.
Let’s talk small cell carcinoma.
Let’s talk small cell carcinoma.
2/ So what exactly is “small cell” carcinoma?
At its core, it’s a high-grade neuroendocrine carcinoma.
That word “neuroendocrine” means these cells share features of both nerve cells and hormone-producing endocrine cells. They’re wired to respond to signals and pump out molecules but in cancer, those same features fuel chaotic, uncontrolled growth.
The term “small cell” comes from what the pathologist sees under the microscope 🔬 : tiny, round, blue cells with almost no cytoplasm, packed tightly together, dividing at a furious pace.
What makes it scary is not just how it looks, but how it behaves. This cancer doesn’t stroll, it sprints🏃🏻♂️. It grows fast, spreads early, and by the time it announces itself clinically, it often has already traveled far beyond the primary site🏎️.
And while most people think “lung” when they hear small cell (and that’s by far the most common), remember: small cell can also show up in other places: prostate, bladder, cervix, GI tract. Same biology, same aggressive tempo.
At its core, it’s a high-grade neuroendocrine carcinoma.
That word “neuroendocrine” means these cells share features of both nerve cells and hormone-producing endocrine cells. They’re wired to respond to signals and pump out molecules but in cancer, those same features fuel chaotic, uncontrolled growth.
The term “small cell” comes from what the pathologist sees under the microscope 🔬 : tiny, round, blue cells with almost no cytoplasm, packed tightly together, dividing at a furious pace.
What makes it scary is not just how it looks, but how it behaves. This cancer doesn’t stroll, it sprints🏃🏻♂️. It grows fast, spreads early, and by the time it announces itself clinically, it often has already traveled far beyond the primary site🏎️.
And while most people think “lung” when they hear small cell (and that’s by far the most common), remember: small cell can also show up in other places: prostate, bladder, cervix, GI tract. Same biology, same aggressive tempo.
3/ Is small cell carcinoma always high-grade? Or can it behave like those low-grade neuroendocrine tumors we sometimes see in the GI tract (like carcinoids)?
Small cell is always high-grade.
That’s what sets it apart from carcinoids. Carcinoids grow slowly 🐢, can sit around for years, and sometimes even make hormones that cause clinical syndromes. Small cell, on the other hand, doesn’t give you that luxury. It’s rapid, destructive, and rarely produces hormones in a clinically obvious way.
So think of it this way:
– Carcinoid = the “well-behaved cousin” 🪽of the neuroendocrine family.
– Small cell = the “chaotic relative” 😈who shows up, burns the house down, and disappears before you can blink.
Small cell is always high-grade.
That’s what sets it apart from carcinoids. Carcinoids grow slowly 🐢, can sit around for years, and sometimes even make hormones that cause clinical syndromes. Small cell, on the other hand, doesn’t give you that luxury. It’s rapid, destructive, and rarely produces hormones in a clinically obvious way.
So think of it this way:
– Carcinoid = the “well-behaved cousin” 🪽of the neuroendocrine family.
– Small cell = the “chaotic relative” 😈who shows up, burns the house down, and disappears before you can blink.
4/ What exactly do we mean by “grade” in neuroendocrine tumors like small cell?
Grade is basically a measure of how angry and fast the cancer cells are 😡. Pathologists look at two things:
– How the cells look under the microscope 🔬 → are they tiny, round, crowded, with almost no cytoplasm and tons of mitoses? That screams high-grade.
– How fast they’re dividing → formally, they check the mitotic rate (how many cells are splitting per high-power field) and/or the Ki-67 index (a stain that lights up dividing cells).
In small cell, the grade is built-in. It’s universally high-grade, with sky-high mitotic counts and Ki-67 often >70–80%. That’s why it grows explosively compared to carcinoid, which has a low mitotic rate and Ki-67 <3%.
So the “grade” isn’t just a label, it’s literally a reflection of how fast this tumor is multiplying and how lethal it’s going to behave.
Grade is basically a measure of how angry and fast the cancer cells are 😡. Pathologists look at two things:
– How the cells look under the microscope 🔬 → are they tiny, round, crowded, with almost no cytoplasm and tons of mitoses? That screams high-grade.
– How fast they’re dividing → formally, they check the mitotic rate (how many cells are splitting per high-power field) and/or the Ki-67 index (a stain that lights up dividing cells).
In small cell, the grade is built-in. It’s universally high-grade, with sky-high mitotic counts and Ki-67 often >70–80%. That’s why it grows explosively compared to carcinoid, which has a low mitotic rate and Ki-67 <3%.
So the “grade” isn’t just a label, it’s literally a reflection of how fast this tumor is multiplying and how lethal it’s going to behave.
5/ So where do you actually see small cell carcinoma?
🫁 Lung – by far the most common. When someone says “small cell,” most people immediately think small cell lung cancer (SCLC).
🍒 Prostate & bladder – the next most common extrapulmonary sites.
🍽️ GI tract – esophagus, stomach, colon.
♀️ Cervix – another recognized site.
🔬 Even rarer: pancreas and a few other organs.
These are all spots where neuroendocrine cells normally live. Small cell hijacks that lineage.
🫁 Lung – by far the most common. When someone says “small cell,” most people immediately think small cell lung cancer (SCLC).
🍒 Prostate & bladder – the next most common extrapulmonary sites.
🍽️ GI tract – esophagus, stomach, colon.
♀️ Cervix – another recognized site.
🔬 Even rarer: pancreas and a few other organs.
These are all spots where neuroendocrine cells normally live. Small cell hijacks that lineage.
6/ Are all lung cancers small cell? 🚫
Not at all. In fact, non–small cell lung cancer (NSCLC) is far more common (~85%). This bucket includes:
– Adenocarcinoma
– Squamous cell carcinoma
NSCLC tends to grow slower and is less aggressive than small cell. Different biology, different playbook.
We’ll dive into NSCLC in another thread.
Not at all. In fact, non–small cell lung cancer (NSCLC) is far more common (~85%). This bucket includes:
– Adenocarcinoma
– Squamous cell carcinoma
NSCLC tends to grow slower and is less aggressive than small cell. Different biology, different playbook.
We’ll dive into NSCLC in another thread.
7/ How does small cell cancer actually present? 🩺
🚨Rapid symptoms → Patients don’t smolder. They get sick fast. Think cough, dyspnea, hemoptysis, chest pain if it’s lung. Outside the lung, symptoms are usually from bulky, fast-growing masses (prostate obstruction, GI bleeding, bladder pain/hematuria).
– Widespread disease at dx → By the time you meet them, most already have metastases (liver, bone, brain).
– Systemic symptoms → Weight loss, night sweats, profound fatigue.
– SVC syndrome🥵: a large mediastinal mass pressing on the superior vena cava. Clinically, that shows up as facial swelling, neck vein distension, and shortness of breath.
🚨Rapid symptoms → Patients don’t smolder. They get sick fast. Think cough, dyspnea, hemoptysis, chest pain if it’s lung. Outside the lung, symptoms are usually from bulky, fast-growing masses (prostate obstruction, GI bleeding, bladder pain/hematuria).
– Widespread disease at dx → By the time you meet them, most already have metastases (liver, bone, brain).
– Systemic symptoms → Weight loss, night sweats, profound fatigue.
– SVC syndrome🥵: a large mediastinal mass pressing on the superior vena cava. Clinically, that shows up as facial swelling, neck vein distension, and shortness of breath.
8/ Clinical presentation can sometimes disguise itself as something else…🎭
Remember when we said these tumors come from neuroendocrine cells, they can actually act like little hormone factories, throwing off the whole body.
– SIADH → tumor makes ADH → water retention + low sodium → confusion, seizures.
– Cushing’s syndrome 🌚 → tumor makes ACTH → cortisol overload → hyperglycemia, round face, muscle wasting.
– Lambert–Eaton 💪🏻→ autoantibodies against calcium channels → proximal muscle weakness (weirdly gets better with activity).
– Hypercalcemia → usually a squamous cell thing, but worth noting from PTHrP.
– Paraneoplastic neuro syndromes → antibodies can attack the brain/cerebellum → ataxia, neuropathy, encephalitis.
That’s why small cell often fools people it can look like an endocrine problem, a neuro problem, or a plain lung problem.
Now I know what you’re thinking 🙄…
These symptoms sound vague. Low sodium? Weak muscles? High sugar? Could be anything.
That’s the catch. Small cell loves to hide in plain sight.
Keep a high index of suspicion especially if the patient has a history of smoking… and of course, learn from threads like these 😉
Remember when we said these tumors come from neuroendocrine cells, they can actually act like little hormone factories, throwing off the whole body.
– SIADH → tumor makes ADH → water retention + low sodium → confusion, seizures.
– Cushing’s syndrome 🌚 → tumor makes ACTH → cortisol overload → hyperglycemia, round face, muscle wasting.
– Lambert–Eaton 💪🏻→ autoantibodies against calcium channels → proximal muscle weakness (weirdly gets better with activity).
– Hypercalcemia → usually a squamous cell thing, but worth noting from PTHrP.
– Paraneoplastic neuro syndromes → antibodies can attack the brain/cerebellum → ataxia, neuropathy, encephalitis.
That’s why small cell often fools people it can look like an endocrine problem, a neuro problem, or a plain lung problem.
Now I know what you’re thinking 🙄…
These symptoms sound vague. Low sodium? Weak muscles? High sugar? Could be anything.
That’s the catch. Small cell loves to hide in plain sight.
Keep a high index of suspicion especially if the patient has a history of smoking… and of course, learn from threads like these 😉
9/ 🧾 So what could the labs show in small cell carcinoma?
In addition to the exam findings we talked about earlier, your basic workup can also raise suspicion for small cell carcinoma.
🧪CBC
– Anemia: very common, can be from chronic disease, marrow infiltration, or even hemolysis.
– Leukocytosis: sometimes present from inflammation or paraneoplastic GM-CSF stimulation.
– Thrombocytopenia: can happen with marrow involvement, but not in every patient.
🧪CMP
– Hyponatremia: classic clue, usually from SIADH (tumor secretes ADH).
– Elevated LFTs: if there’s liver metastasis or infiltration.
– High LDH: reflects rapid tumor cell turnover, often a marker of aggressive disease.
– Hypercalcemia: less typical in small cell, but can occur if there’s ectopic PTHrP.
🩻 Chest X-ray
– Often shows a central or hilar mass, bulky mediastinal nodes, or even diffuse infiltration if lung carcinoma is the case. But sometimes, it’s surprisingly subtle.
⚠️ Important caveat:
These abnormalities don’t all come at once. You might just see anemia, or only hyponatremia, or just a central mass on CXR. Small cell often disguises itself with one or two clues it’s rarely the full “checklist” presentation.
In addition to the exam findings we talked about earlier, your basic workup can also raise suspicion for small cell carcinoma.
🧪CBC
– Anemia: very common, can be from chronic disease, marrow infiltration, or even hemolysis.
– Leukocytosis: sometimes present from inflammation or paraneoplastic GM-CSF stimulation.
– Thrombocytopenia: can happen with marrow involvement, but not in every patient.
🧪CMP
– Hyponatremia: classic clue, usually from SIADH (tumor secretes ADH).
– Elevated LFTs: if there’s liver metastasis or infiltration.
– High LDH: reflects rapid tumor cell turnover, often a marker of aggressive disease.
– Hypercalcemia: less typical in small cell, but can occur if there’s ectopic PTHrP.
🩻 Chest X-ray
– Often shows a central or hilar mass, bulky mediastinal nodes, or even diffuse infiltration if lung carcinoma is the case. But sometimes, it’s surprisingly subtle.
⚠️ Important caveat:
These abnormalities don’t all come at once. You might just see anemia, or only hyponatremia, or just a central mass on CXR. Small cell often disguises itself with one or two clues it’s rarely the full “checklist” presentation.
10/ You’ve got your CBC, CMP, maybe even a chest X-ray, and small cell is creeping onto your differential. What do you actually do with that suspicion?
1️⃣Get better imaging. 📸 A chest/abdomen/pelvis CT is usually your first move. A plain chest X-ray might show a mass, but a CT will tell you size, location, nodal involvement, and whether you’ve got spread to organs like the liver or adrenals.
2️⃣Confirm with tissue. 🔪Small cell cannot be diagnosed without a biopsy 🔬. This might be through bronchoscopy if the mass is central, a lymph node excision, or even a liver biopsy if that’s the easiest access point. Remember to always chase the site that is most likely to upstage the cancer, meaning distant is better than primary. The pathologist has to see those classic “small round blue cells” and confirm with stains.
3️⃣Don’t forget the brain. 🧠 Unlike most cancers, small cell loves the brain early. Once you confirm the diagnosis, a brain MRI is pretty much always part of the staging workup. Sometimes the brain lesions are there before the patient even has lung symptoms.
4️⃣Loop in oncology fast. ☎️This is not a “wait for outpatient follow-up” kind of disease. Small cell grows and spreads aggressively. The sooner you confirm, the sooner the patient gets on systemic therapy, and that’s what really changes outcomes.
1️⃣Get better imaging. 📸 A chest/abdomen/pelvis CT is usually your first move. A plain chest X-ray might show a mass, but a CT will tell you size, location, nodal involvement, and whether you’ve got spread to organs like the liver or adrenals.
2️⃣Confirm with tissue. 🔪Small cell cannot be diagnosed without a biopsy 🔬. This might be through bronchoscopy if the mass is central, a lymph node excision, or even a liver biopsy if that’s the easiest access point. Remember to always chase the site that is most likely to upstage the cancer, meaning distant is better than primary. The pathologist has to see those classic “small round blue cells” and confirm with stains.
3️⃣Don’t forget the brain. 🧠 Unlike most cancers, small cell loves the brain early. Once you confirm the diagnosis, a brain MRI is pretty much always part of the staging workup. Sometimes the brain lesions are there before the patient even has lung symptoms.
4️⃣Loop in oncology fast. ☎️This is not a “wait for outpatient follow-up” kind of disease. Small cell grows and spreads aggressively. The sooner you confirm, the sooner the patient gets on systemic therapy, and that’s what really changes outcomes.
11/ Can you tell if a lung cancer is small cell just by looking at the CT? 🤔
Not with 100% certainty. But there are patterns that should make you suspicious:
– 🔴 Central bulky mass: small cell usually starts near the bronchi in the hilum/mediastinum.
– 🔴 Big mediastinal nodes: sometimes the nodes look way larger than the main tumor.
– 🔴 Compression effects: trachea squeezed, bronchi narrowed, or SVC syndrome (think: facial swelling, jugular distension, dyspnea).
– 🔴 Early spread liver, adrenal, or bone lesions can already be there at diagnosis.
Not with 100% certainty. But there are patterns that should make you suspicious:
– 🔴 Central bulky mass: small cell usually starts near the bronchi in the hilum/mediastinum.
– 🔴 Big mediastinal nodes: sometimes the nodes look way larger than the main tumor.
– 🔴 Compression effects: trachea squeezed, bronchi narrowed, or SVC syndrome (think: facial swelling, jugular distension, dyspnea).
– 🔴 Early spread liver, adrenal, or bone lesions can already be there at diagnosis.
12/ “💭How fast can pathology actually tell me if this is small cell? And what do I do in the meantime?…🤔”
– A prelim read from a bronchoscopic biopsy or EBUS can come back in 24–48h, sometimes even sooner.
– For confirmation, pathologists run immunohistochemistry stains. These involve bathing the tumor tissue in antibodies that “light up” specific proteins. For small cell, the classics are:
– CD56
– Synaptophysin
– Chromogranin
All three are markers of neuroendocrine differentiation, which is what defines small cell.
– A prelim read from a bronchoscopic biopsy or EBUS can come back in 24–48h, sometimes even sooner.
– For confirmation, pathologists run immunohistochemistry stains. These involve bathing the tumor tissue in antibodies that “light up” specific proteins. For small cell, the classics are:
– CD56
– Synaptophysin
– Chromogranin
All three are markers of neuroendocrine differentiation, which is what defines small cell.
13/ While you wait, you focus on:
– Stabilizing the patient: oxygen, fluids, pain control, nutrition.
– Managing metabolic issues: correct hyponatremia (SIADH), hypercalcemia (rare but possible with bone mets), hypokalemia or arrhythmias if present.
– Addressing cytopenias: transfuse if severe anemia or thrombocytopenia, start infection workup if neutropenic fever.
– Protecting organs: monitor liver and kidney function (mets can cause dysfunction; therapy will need baselines).
– Planning ahead: get baseline HIV and viral hep panel if you think chemo will start soon. Prepare for IV access.
Managing complications:
– SVC syndrome is a classic emergency in small cell.
– Spinal cord compression → emergent MRI + steroids.
– Brain mets → neuro consult, consider MRI brain, steroids for edema.
(I’ve already broken each of these down in detail in separate threads; check my thread library at the end of this post for step-by-step management.)
– Stabilizing the patient: oxygen, fluids, pain control, nutrition.
– Managing metabolic issues: correct hyponatremia (SIADH), hypercalcemia (rare but possible with bone mets), hypokalemia or arrhythmias if present.
– Addressing cytopenias: transfuse if severe anemia or thrombocytopenia, start infection workup if neutropenic fever.
– Protecting organs: monitor liver and kidney function (mets can cause dysfunction; therapy will need baselines).
– Planning ahead: get baseline HIV and viral hep panel if you think chemo will start soon. Prepare for IV access.
Managing complications:
– SVC syndrome is a classic emergency in small cell.
– Spinal cord compression → emergent MRI + steroids.
– Brain mets → neuro consult, consider MRI brain, steroids for edema.
(I’ve already broken each of these down in detail in separate threads; check my thread library at the end of this post for step-by-step management.)
14/ Small Cell + Brain Mets: Steroids or No Steroids?
Let’s assume MRI brain showed brain mets. Now what?
You’ve probably heard that in the upfront treatment of extensive-stage small cell lung cancer, chemotherapy + immunotherapy is now part of the standard regimen. 🚀
Here’s where things get tricky: steroids. 💊
We know they can be life-saving in brain mets (reduce swelling, prevent herniation). But there are also reports that steroids given before immunotherapy may blunt the immune response raising the question of whether they reduce the benefit of treatment.
So what do you do if your patient with small cell shows up with brain metastases? Let’s walk through it. 👇
– If they’re asymptomatic, you can usually hold off on steroids. Chemo ± immunotherapy might come first, and it’s reasonable to wait.
– But if they’re symptomatic (neuro deficits, headache, seizures), things get tricky. Steroids may be life-saving here.
👉 Always loop in oncology, radiation oncology, and neurosurgery right away. They’ll guide whether to start the lowest effective dose of steroids and how soon to deliver radiation.
💥 Radiation is the best tool to hammer those brain metastases. But timing matters:
– If the disease outside the brain is very bulky and urgent to control, chemo may take priority first.
– In some cases, oncology might give one cycle of chemo inpatient, then squeeze in radiation right before the second cycle. This avoids overlapping toxicities from doing both at the same time.
📝 And here’s the key: these guidelines are constantly evolving. There’s no one-size-fits-all. Each case is different, which is why multidisciplinary input is critical.
Let’s assume MRI brain showed brain mets. Now what?
You’ve probably heard that in the upfront treatment of extensive-stage small cell lung cancer, chemotherapy + immunotherapy is now part of the standard regimen. 🚀
Here’s where things get tricky: steroids. 💊
We know they can be life-saving in brain mets (reduce swelling, prevent herniation). But there are also reports that steroids given before immunotherapy may blunt the immune response raising the question of whether they reduce the benefit of treatment.
So what do you do if your patient with small cell shows up with brain metastases? Let’s walk through it. 👇
– If they’re asymptomatic, you can usually hold off on steroids. Chemo ± immunotherapy might come first, and it’s reasonable to wait.
– But if they’re symptomatic (neuro deficits, headache, seizures), things get tricky. Steroids may be life-saving here.
👉 Always loop in oncology, radiation oncology, and neurosurgery right away. They’ll guide whether to start the lowest effective dose of steroids and how soon to deliver radiation.
💥 Radiation is the best tool to hammer those brain metastases. But timing matters:
– If the disease outside the brain is very bulky and urgent to control, chemo may take priority first.
– In some cases, oncology might give one cycle of chemo inpatient, then squeeze in radiation right before the second cycle. This avoids overlapping toxicities from doing both at the same time.
📝 And here’s the key: these guidelines are constantly evolving. There’s no one-size-fits-all. Each case is different, which is why multidisciplinary input is critical.
15/ Should you start TLS prophylaxis in small cell carcinoma?
For most solid tumors, TLS is rare. But small cell is the exception, it grows fast, and yes, TLS can happen. Not as often as in acute leukemias, but I’ve seen it more than once in practice.
Here’s the nuance:
– Not every patient needs prophylaxis.
– High-risk patients (big bulky disease, heavy liver mets, sky-high LDH/uric acid, or baseline kidney dysfunction) → that’s when you worry.
– For those, it’s reasonable to start aggressive hydration + urate-lowering meds (allopurinol, sometimes rasburicase).
Others? Many providers just do close inpatient monitoring with frequent labs and jump in if things shift.
For a detailed plan on TLS prophylaxis and management, check out my thread on acute leukemia 👇🏻
For most solid tumors, TLS is rare. But small cell is the exception, it grows fast, and yes, TLS can happen. Not as often as in acute leukemias, but I’ve seen it more than once in practice.
Here’s the nuance:
– Not every patient needs prophylaxis.
– High-risk patients (big bulky disease, heavy liver mets, sky-high LDH/uric acid, or baseline kidney dysfunction) → that’s when you worry.
– For those, it’s reasonable to start aggressive hydration + urate-lowering meds (allopurinol, sometimes rasburicase).
Others? Many providers just do close inpatient monitoring with frequent labs and jump in if things shift.
For a detailed plan on TLS prophylaxis and management, check out my thread on acute leukemia 👇🏻
16/ 🏥 So what does an inpatient admission for small cell carcinoma actually look like?
👉 In most cases, oncology will start chemotherapy right away usually a platinum doublet:
– Cisplatin + etoposide
– or Carboplatin + etoposide
💉 These regimens are typically given over 3–5 days. Patients are usually discharged the last day of chemo or the following day, once they’re stable.
Why inpatient?
The first cycle is higher risk for complications (tumor lysis, cytopenias, infections, organ stress). If the patient tolerates cycle 1, the following cycles are almost always done outpatient.
💊 What about immunotherapy?
It’s often part of the upfront regimen for extensive-stage small cell, but you won’t see it inpatient. Insurance rarely covers it in the hospital, so immunotherapy usually begins with cycle 2, outpatient.
🔦 Radiation?
If planned, that’s also typically handled in the outpatient setting after stabilization.
👉 In most cases, oncology will start chemotherapy right away usually a platinum doublet:
– Cisplatin + etoposide
– or Carboplatin + etoposide
💉 These regimens are typically given over 3–5 days. Patients are usually discharged the last day of chemo or the following day, once they’re stable.
Why inpatient?
The first cycle is higher risk for complications (tumor lysis, cytopenias, infections, organ stress). If the patient tolerates cycle 1, the following cycles are almost always done outpatient.
💊 What about immunotherapy?
It’s often part of the upfront regimen for extensive-stage small cell, but you won’t see it inpatient. Insurance rarely covers it in the hospital, so immunotherapy usually begins with cycle 2, outpatient.
🔦 Radiation?
If planned, that’s also typically handled in the outpatient setting after stabilization.
17/ 💭 “Do patients with small cell carcinoma need antimicrobial prophylaxis or allopurinol after discharge?”🤔
👉 Antimicrobials: Usually no. Unlike leukemias, these patients aren’t profoundly neutropenic after their first cycle, so routine antibiotic/antifungal/antiviral prophylaxis isn’t needed.
👉 Allopurinol:
– If uric acid was normal at baseline and stable at discharge → you can stop on discharge.
– If uric acid was high at baseline or electrolytes are still a little off → many clinicians will continue allopurinol for 1–2 weeks, or until the next chemo cycle.
⚖️ Bottom line: This isn’t one-size-fits-all. Practices vary a bit by institution, but most centers don’t send every small cell patient home on prophylaxis.
👉 Antimicrobials: Usually no. Unlike leukemias, these patients aren’t profoundly neutropenic after their first cycle, so routine antibiotic/antifungal/antiviral prophylaxis isn’t needed.
👉 Allopurinol:
– If uric acid was normal at baseline and stable at discharge → you can stop on discharge.
– If uric acid was high at baseline or electrolytes are still a little off → many clinicians will continue allopurinol for 1–2 weeks, or until the next chemo cycle.
⚖️ Bottom line: This isn’t one-size-fits-all. Practices vary a bit by institution, but most centers don’t send every small cell patient home on prophylaxis.
18/ 💭“Okay, but what about small cell outside the lung? Do we treat that differently?”🤔
Here’s the thing:
– Extrapulmonary small cell carcinomas (prostate, bladder, GI, cervix, etc.) are rare, but they behave biologically just like small cell lung cancer — aggressive, fast-growing, and highly responsive to chemo.
– Because of this, we borrow treatment strategies from lung small cell. That means platinum-based chemo (cisplatin or carboplatin + etoposide) is the backbone.
– Immunotherapy? Still evolving in this space — data isn’t as robust as lung, but clinical trials are ongoing.
⚠️ Key nuance:
Outcomes in extrapulmonary disease can sometimes be worse because diagnosis is delayed, and by the time it’s caught, it’s often advanced.
So bottom line: If you see “small cell” anywhere outside the lung, think high-grade, aggressive neuroendocrine, and treat it like lung small cell until proven otherwise.
Here’s the thing:
– Extrapulmonary small cell carcinomas (prostate, bladder, GI, cervix, etc.) are rare, but they behave biologically just like small cell lung cancer — aggressive, fast-growing, and highly responsive to chemo.
– Because of this, we borrow treatment strategies from lung small cell. That means platinum-based chemo (cisplatin or carboplatin + etoposide) is the backbone.
– Immunotherapy? Still evolving in this space — data isn’t as robust as lung, but clinical trials are ongoing.
⚠️ Key nuance:
Outcomes in extrapulmonary disease can sometimes be worse because diagnosis is delayed, and by the time it’s caught, it’s often advanced.
So bottom line: If you see “small cell” anywhere outside the lung, think high-grade, aggressive neuroendocrine, and treat it like lung small cell until proven otherwise.
19/ 💭 “So what’s the prognosis with small cell carcinoma?”🤔
Let me put it this way: small cell is a paradox.
On one hand, it’s one of the fastest-growing tumors we see in oncology. Patients often present sick, symptomatic, with bulky disease.
But the moment chemotherapy (platinum + etoposide) is infused, it’s like watching a switch flip . Tumors that were choking airways, flooding the liver, or weighing patients down start to shrink within days. Patients feel their breathing improve, their pain lighten, their appetite return.
It’s dramatic. In fact, oncologists often say: “small cell melts.” 🫠 That’s not poetry that’s exactly how it behaves.
But here’s the tragedy: while small cell melts, it also comes roaring back. Resistance develops quickly, sometimes within months. And unlike the first response, the second is never as strong. That’s why, despite initial chemosensitivity, the median survival remains modest.
🔥🧊 Think of it like fire and ice: it burns fast, but it also melts fast. And then it returns just as fiercely.
That’s the bittersweet reality of small cell tumors that vanish before your eyes, only to reappear with a vengeance.
Let me put it this way: small cell is a paradox.
On one hand, it’s one of the fastest-growing tumors we see in oncology. Patients often present sick, symptomatic, with bulky disease.
But the moment chemotherapy (platinum + etoposide) is infused, it’s like watching a switch flip . Tumors that were choking airways, flooding the liver, or weighing patients down start to shrink within days. Patients feel their breathing improve, their pain lighten, their appetite return.
It’s dramatic. In fact, oncologists often say: “small cell melts.” 🫠 That’s not poetry that’s exactly how it behaves.
But here’s the tragedy: while small cell melts, it also comes roaring back. Resistance develops quickly, sometimes within months. And unlike the first response, the second is never as strong. That’s why, despite initial chemosensitivity, the median survival remains modest.
🔥🧊 Think of it like fire and ice: it burns fast, but it also melts fast. And then it returns just as fiercely.
That’s the bittersweet reality of small cell tumors that vanish before your eyes, only to reappear with a vengeance.
And that’s a wrap, folks! That’s it for today.
If you’ve been following along, I’m hoping to grow this series into a go-to resource for hospital-based docs navigating hematology oncology cases.
Open to suggestions or feedback.
If you like this format, like, repost, and share the love.
Also, below is a link to the library thread with all my episodes so far 👇🏻
If you’ve been following along, I’m hoping to grow this series into a go-to resource for hospital-based docs navigating hematology oncology cases.
Open to suggestions or feedback.
If you like this format, like, repost, and share the love.
Also, below is a link to the library thread with all my episodes so far 👇🏻
• • •
Missing some Tweet in this thread? You can try to
force a refresh
